| Paige J Smith, MD | |
|
1622 Westgate Cir, Brentwood, TN 37027-8019 | |
| (629) 255-2219 | |
| (629) 255-4125 |
| Full Name | Paige J Smith |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1622 Westgate Cir, Brentwood, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376630418 | NPI | - | NPPES |
| Q018319 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD40186 (Tennessee) | Primary |
| Entity Name | Heritage Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548284060 PECOS PAC ID: 4688651037 Enrollment ID: O20040702000463 |
News Archive
Progenics Pharmaceuticals, Inc. today announced the initiation of an international 700-patient, phase 3 trial of oral methylnaltrexone in patients with chronic, non-cancer pain who are experiencing constipation as a result of their opioid-pain management regimens. The goal of the study is to evaluate the safety and efficacy of oral methylnaltrexone to treat opioid-induced constipation (OIC) in this patient setting.
Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.
Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, has expanded its Eating Disorder Specialist Library to further help sufferers of anorexia, bulimia and binge eating disorder find treatment options.
The University of Colorado Denver announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paige J Smith, MD 222 22nd Ave N, Nashville, TN 37203-1852 Ph: (629) 255-3486 | Paige J Smith, MD 1622 Westgate Cir, Brentwood, TN 37027-8019 Ph: (629) 255-2219 |
News Archive
Progenics Pharmaceuticals, Inc. today announced the initiation of an international 700-patient, phase 3 trial of oral methylnaltrexone in patients with chronic, non-cancer pain who are experiencing constipation as a result of their opioid-pain management regimens. The goal of the study is to evaluate the safety and efficacy of oral methylnaltrexone to treat opioid-induced constipation (OIC) in this patient setting.
Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Meclizine Hydrochloride Tablets USP, 12.5 mg, 25 mg and 50 mg.
Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, has expanded its Eating Disorder Specialist Library to further help sufferers of anorexia, bulimia and binge eating disorder find treatment options.
The University of Colorado Denver announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges.
› Verified 9 days ago
Dr. Leah Marie Umphlett, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5111 Maryland Way Ste 301, Brentwood, TN 37027 Phone: 615-661-4256 Fax: 615-661-4253 | |
Elizabeth Louise Mcfarlin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 343 Franklin Rd, Ste 210, Brentwood, TN 37027 Phone: 615-373-2248 Fax: 615-373-5116 | |
Dr. Christina M Lohse, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2187 Fax: 629-255-4234 | |
Dr. Charles A Moss, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 95 Seaboard Ln, Suite 201, Brentwood, TN 37027 Phone: 615-261-1214 Fax: 615-261-1222 | |
Dr. Bram I Pinkley, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2177 Fax: 629-255-4235 | |
Dorsey Andrews Rickard, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1607 Westgate Cir Ste 200, Brentwood, TN 37027 Phone: 615-376-8195 Fax: 615-376-2601 | |
Cory Brooks Collier, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7003 Chadwick Dr Ste 298, Brentwood, TN 37027 Phone: 615-750-3774 Fax: 615-442-8273 |